Member news

Adrenomed’s Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II

More at adrenomed.com…

MagForce AG successfully completes installation of mobile NanoTherm treatment center for brain tumors in Poland

More at magforce.com…

Heidelberg Pharma announces financial figures for fiscal year 2018 and provides business update

More at heidelberg-pharma.com…

Topas Therapeutics to Participate at Upcoming Industry and Scientific Conferences

More at topas-therapeutics.com…

PAION: Annual financial report 2018 (includes Group and AG reports)

More at paion.com…

Probiodrug and Alzheimer’s Disease Cooperative Study (ADCS) Receive 15 Million USD National Institutes of Health (NIH) Grant for U.S. Phase 2b Core Program for PQ912

More at probiodrug.de…